 | • レポートコード：MRC2Q12-19230 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、メチルコバラミン（メコバラミン）のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 メチルコバラミン（メコバラミン）のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 メチルコバラミン（メコバラミン）の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 メチルコバラミン（メコバラミン）のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのメチルコバラミン（メコバラミン）の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のメチルコバラミン（メコバラミン）の売上および2028年までの予測に焦点を当てています。 メチルコバラミン（メコバラミン）のグローバル主要企業には、Sihuan Shengwu、Hiteck Biological Pharma、Chunfeng Pharma、Hassun、Eisai、Renhe Group、Dandong Medical Innovation Pharmaceutical、Sunho、SJZ No.4 Pharma、Dongle Pharma、Conba Bio-Pharm、WZT、Medisan、Sunflower Pharmaceutical Group、Nipro、Towa Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 メチルコバラミン（メコバラミン）市場は、タイプとアプリケーションによって区分されます。世界のメチルコバラミン（メコバラミン）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 錠剤、溶液、カプセル 【アプリケーション別セグメント】 巨赤芽球性貧血、亜急性脊髄複合体変性症 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - メチルコバラミン（メコバラミン）製品概要 - タイプ別市場（錠剤、溶液、カプセル） - アプリケーション別市場（巨赤芽球性貧血、亜急性脊髄複合体変性症） - 調査の目的 ・エグゼクティブサマリー - 世界のメチルコバラミン（メコバラミン）販売量予測2017-2028 - 世界のメチルコバラミン（メコバラミン）売上予測2017-2028 - メチルコバラミン（メコバラミン）の地域別販売量 - メチルコバラミン（メコバラミン）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別メチルコバラミン（メコバラミン）販売量 - 主要メーカー別メチルコバラミン（メコバラミン）売上 - 主要メーカー別メチルコバラミン（メコバラミン）価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（錠剤、溶液、カプセル） - メチルコバラミン（メコバラミン）のタイプ別販売量 - メチルコバラミン（メコバラミン）のタイプ別売上 - メチルコバラミン（メコバラミン）のタイプ別価格 ・アプリケーション別市場規模（巨赤芽球性貧血、亜急性脊髄複合体変性症） - メチルコバラミン（メコバラミン）のアプリケーション別販売量 - メチルコバラミン（メコバラミン）のアプリケーション別売上 - メチルコバラミン（メコバラミン）のアプリケーション別価格 ・北米市場 - 北米のメチルコバラミン（メコバラミン）市場規模（タイプ別、アプリケーション別） - 主要国別のメチルコバラミン（メコバラミン）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのメチルコバラミン（メコバラミン）市場規模（タイプ別、アプリケーション別） - 主要国別のメチルコバラミン（メコバラミン）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のメチルコバラミン（メコバラミン）市場規模（タイプ別、アプリケーション別） - 主要国別のメチルコバラミン（メコバラミン）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のメチルコバラミン（メコバラミン）市場規模（タイプ別、アプリケーション別） - 主要国別のメチルコバラミン（メコバラミン）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのメチルコバラミン（メコバラミン）市場規模（タイプ別、アプリケーション別） - 主要国別のメチルコバラミン（メコバラミン）市場規模（トルコ、サウジアラビア） ・企業情報 Sihuan Shengwu、Hiteck Biological Pharma、Chunfeng Pharma、Hassun、Eisai、Renhe Group、Dandong Medical Innovation Pharmaceutical、Sunho、SJZ No.4 Pharma、Dongle Pharma、Conba Bio-Pharm、WZT、Medisan、Sunflower Pharmaceutical Group、Nipro、Towa Pharma ・産業チェーン及び販売チャネル分析 - メチルコバラミン（メコバラミン）の産業チェーン分析 - メチルコバラミン（メコバラミン）の原材料 - メチルコバラミン（メコバラミン）の生産プロセス - メチルコバラミン（メコバラミン）の販売及びマーケティング - メチルコバラミン（メコバラミン）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - メチルコバラミン（メコバラミン）の産業動向 - メチルコバラミン（メコバラミン）のマーケットドライバー - メチルコバラミン（メコバラミン）の課題 - メチルコバラミン（メコバラミン）の阻害要因 ・主な調査結果 |
Methylcobalamin (mecobalamin, MeCbl, or MeB12) is a cobalamin, a form of vitamin B12
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Methylcobalamin(Mecobalamin) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Methylcobalamin(Mecobalamin) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Methylcobalamin(Mecobalamin) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Methylcobalamin(Mecobalamin) include Sihuan Shengwu, Hiteck Biological Pharma, Chunfeng Pharma, Hassun, Eisai, Renhe Group, Dandong Medical Innovation Pharmaceutical, Sunho and SJZ No.4 Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Methylcobalamin(Mecobalamin) manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Methylcobalamin(Mecobalamin) market. Further, it explains the major drivers and regional dynamics of the global Methylcobalamin(Mecobalamin) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Sihuan Shengwu
Hiteck Biological Pharma
Chunfeng Pharma
Hassun
Eisai
Renhe Group
Dandong Medical Innovation Pharmaceutical
Sunho
SJZ No.4 Pharma
Dongle Pharma
Conba Bio-Pharm
WZT
Medisan
Sunflower Pharmaceutical Group
Nipro
Towa Pharma
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by dosage form and by application segments based on sales, price, and value for the period 2017-2028.
Methylcobalamin(Mecobalamin) Segment by Dosage Form
Tablets
Solution
Capsule
Methylcobalamin(Mecobalamin) Segment by Application
Megaloblastic Anemia
Subacute Combined Degeneration of the Spinal Cord
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Methylcobalamin(Mecobalamin) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Methylcobalamin(Mecobalamin), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Methylcobalamin(Mecobalamin), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Methylcobalamin(Mecobalamin), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Methylcobalamin(Mecobalamin) sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Methylcobalamin(Mecobalamin) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Methylcobalamin(Mecobalamin) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sihuan Shengwu, Hiteck Biological Pharma, Chunfeng Pharma, Hassun, Eisai, Renhe Group, Dandong Medical Innovation Pharmaceutical, Sunho and SJZ No.4 Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Methylcobalamin(Mecobalamin) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Methylcobalamin(Mecobalamin) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by dosage form, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by dosage form, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by dosage form, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Methylcobalamin(Mecobalamin) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Methylcobalamin(Mecobalamin) Product Introduction
1.2 Market by Dosage Form
1.2.1 Global Methylcobalamin(Mecobalamin) Market Size Growth Rate by Dosage Form, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Solution
1.2.4 Capsule
1.3 Market by Application
1.3.1 Global Methylcobalamin(Mecobalamin) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Megaloblastic Anemia
1.3.3 Subacute Combined Degeneration of the Spinal Cord
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Methylcobalamin(Mecobalamin) Sales Estimates and Forecasts 2017-2028
2.2 Global Methylcobalamin(Mecobalamin) Revenue Estimates and Forecasts 2017-2028
2.3 Global Methylcobalamin(Mecobalamin) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Methylcobalamin(Mecobalamin) Sales by Region
2.4.1 Global Methylcobalamin(Mecobalamin) Sales by Region (2017-2022)
2.4.2 Global Sales Methylcobalamin(Mecobalamin) by Region (2023-2028)
2.5 Global Methylcobalamin(Mecobalamin) Revenue by Region
2.5.1 Global Methylcobalamin(Mecobalamin) Revenue by Region (2017-2022)
2.5.2 Global Methylcobalamin(Mecobalamin) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Methylcobalamin(Mecobalamin) Sales by Manufacturers
3.1.1 Global Top Methylcobalamin(Mecobalamin) Manufacturers by Sales (2017-2022)
3.1.2 Global Methylcobalamin(Mecobalamin) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Methylcobalamin(Mecobalamin) in 2021
3.2 Global Methylcobalamin(Mecobalamin) Revenue by Manufacturers
3.2.1 Global Methylcobalamin(Mecobalamin) Revenue by Manufacturers (2017-2022)
3.2.2 Global Methylcobalamin(Mecobalamin) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Methylcobalamin(Mecobalamin) Revenue in 2021
3.3 Global Methylcobalamin(Mecobalamin) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Methylcobalamin(Mecobalamin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Methylcobalamin(Mecobalamin) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Dosage Form
4.1 Global Methylcobalamin(Mecobalamin) Sales by Dosage Form
4.1.1 Global Methylcobalamin(Mecobalamin) Historical Sales by Dosage Form (2017-2022)
4.1.2 Global Methylcobalamin(Mecobalamin) Forecasted Sales by Dosage Form (2023-2028)
4.1.3 Global Methylcobalamin(Mecobalamin) Sales Market Share by Dosage Form (2017-2028)
4.2 Global Methylcobalamin(Mecobalamin) Revenue by Dosage Form
4.2.1 Global Methylcobalamin(Mecobalamin) Historical Revenue by Dosage Form (2017-2022)
4.2.2 Global Methylcobalamin(Mecobalamin) Forecasted Revenue by Dosage Form (2023-2028)
4.2.3 Global Methylcobalamin(Mecobalamin) Revenue Market Share by Dosage Form (2017-2028)
4.3 Global Methylcobalamin(Mecobalamin) Price by Dosage Form
4.3.1 Global Methylcobalamin(Mecobalamin) Price by Dosage Form (2017-2022)
4.3.2 Global Methylcobalamin(Mecobalamin) Price Forecast by Dosage Form (2023-2028)
5 Market Size by Application
5.1 Global Methylcobalamin(Mecobalamin) Sales by Application
5.1.1 Global Methylcobalamin(Mecobalamin) Historical Sales by Application (2017-2022)
5.1.2 Global Methylcobalamin(Mecobalamin) Forecasted Sales by Application (2023-2028)
5.1.3 Global Methylcobalamin(Mecobalamin) Sales Market Share by Application (2017-2028)
5.2 Global Methylcobalamin(Mecobalamin) Revenue by Application
5.2.1 Global Methylcobalamin(Mecobalamin) Historical Revenue by Application (2017-2022)
5.2.2 Global Methylcobalamin(Mecobalamin) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Methylcobalamin(Mecobalamin) Revenue Market Share by Application (2017-2028)
5.3 Global Methylcobalamin(Mecobalamin) Price by Application
5.3.1 Global Methylcobalamin(Mecobalamin) Price by Application (2017-2022)
5.3.2 Global Methylcobalamin(Mecobalamin) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Methylcobalamin(Mecobalamin) Market Size by Dosage Form
6.1.1 North America Methylcobalamin(Mecobalamin) Sales by Dosage Form (2017-2028)
6.1.2 North America Methylcobalamin(Mecobalamin) Revenue by Dosage Form (2017-2028)
6.2 North America Methylcobalamin(Mecobalamin) Market Size by Application
6.2.1 North America Methylcobalamin(Mecobalamin) Sales by Application (2017-2028)
6.2.2 North America Methylcobalamin(Mecobalamin) Revenue by Application (2017-2028)
6.3 North America Methylcobalamin(Mecobalamin) Market Size by Country
6.3.1 North America Methylcobalamin(Mecobalamin) Sales by Country (2017-2028)
6.3.2 North America Methylcobalamin(Mecobalamin) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Methylcobalamin(Mecobalamin) Market Size by Dosage Form
7.1.1 Europe Methylcobalamin(Mecobalamin) Sales by Dosage Form (2017-2028)
7.1.2 Europe Methylcobalamin(Mecobalamin) Revenue by Dosage Form (2017-2028)
7.2 Europe Methylcobalamin(Mecobalamin) Market Size by Application
7.2.1 Europe Methylcobalamin(Mecobalamin) Sales by Application (2017-2028)
7.2.2 Europe Methylcobalamin(Mecobalamin) Revenue by Application (2017-2028)
7.3 Europe Methylcobalamin(Mecobalamin) Market Size by Country
7.3.1 Europe Methylcobalamin(Mecobalamin) Sales by Country (2017-2028)
7.3.2 Europe Methylcobalamin(Mecobalamin) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Methylcobalamin(Mecobalamin) Market Size by Dosage Form
8.1.1 Asia Pacific Methylcobalamin(Mecobalamin) Sales by Dosage Form (2017-2028)
8.1.2 Asia Pacific Methylcobalamin(Mecobalamin) Revenue by Dosage Form (2017-2028)
8.2 Asia Pacific Methylcobalamin(Mecobalamin) Market Size by Application
8.2.1 Asia Pacific Methylcobalamin(Mecobalamin) Sales by Application (2017-2028)
8.2.2 Asia Pacific Methylcobalamin(Mecobalamin) Revenue by Application (2017-2028)
8.3 Asia Pacific Methylcobalamin(Mecobalamin) Market Size by Region
8.3.1 Asia Pacific Methylcobalamin(Mecobalamin) Sales by Region (2017-2028)
8.3.2 Asia Pacific Methylcobalamin(Mecobalamin) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Methylcobalamin(Mecobalamin) Market Size by Dosage Form
9.1.1 Latin America Methylcobalamin(Mecobalamin) Sales by Dosage Form (2017-2028)
9.1.2 Latin America Methylcobalamin(Mecobalamin) Revenue by Dosage Form (2017-2028)
9.2 Latin America Methylcobalamin(Mecobalamin) Market Size by Application
9.2.1 Latin America Methylcobalamin(Mecobalamin) Sales by Application (2017-2028)
9.2.2 Latin America Methylcobalamin(Mecobalamin) Revenue by Application (2017-2028)
9.3 Latin America Methylcobalamin(Mecobalamin) Market Size by Country
9.3.1 Latin America Methylcobalamin(Mecobalamin) Sales by Country (2017-2028)
9.3.2 Latin America Methylcobalamin(Mecobalamin) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Methylcobalamin(Mecobalamin) Market Size by Dosage Form
10.1.1 Middle East and Africa Methylcobalamin(Mecobalamin) Sales by Dosage Form (2017-2028)
10.1.2 Middle East and Africa Methylcobalamin(Mecobalamin) Revenue by Dosage Form (2017-2028)
10.2 Middle East and Africa Methylcobalamin(Mecobalamin) Market Size by Application
10.2.1 Middle East and Africa Methylcobalamin(Mecobalamin) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Methylcobalamin(Mecobalamin) Revenue by Application (2017-2028)
10.3 Middle East and Africa Methylcobalamin(Mecobalamin) Market Size by Country
10.3.1 Middle East and Africa Methylcobalamin(Mecobalamin) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Methylcobalamin(Mecobalamin) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sihuan Shengwu
11.1.1 Sihuan Shengwu Corporation Information
11.1.2 Sihuan Shengwu Overview
11.1.3 Sihuan Shengwu Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sihuan Shengwu Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sihuan Shengwu Recent Developments
11.2 Hiteck Biological Pharma
11.2.1 Hiteck Biological Pharma Corporation Information
11.2.2 Hiteck Biological Pharma Overview
11.2.3 Hiteck Biological Pharma Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Hiteck Biological Pharma Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hiteck Biological Pharma Recent Developments
11.3 Chunfeng Pharma
11.3.1 Chunfeng Pharma Corporation Information
11.3.2 Chunfeng Pharma Overview
11.3.3 Chunfeng Pharma Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Chunfeng Pharma Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chunfeng Pharma Recent Developments
11.4 Hassun
11.4.1 Hassun Corporation Information
11.4.2 Hassun Overview
11.4.3 Hassun Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hassun Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hassun Recent Developments
11.5 Eisai
11.5.1 Eisai Corporation Information
11.5.2 Eisai Overview
11.5.3 Eisai Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eisai Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eisai Recent Developments
11.6 Renhe Group
11.6.1 Renhe Group Corporation Information
11.6.2 Renhe Group Overview
11.6.3 Renhe Group Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Renhe Group Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Renhe Group Recent Developments
11.7 Dandong Medical Innovation Pharmaceutical
11.7.1 Dandong Medical Innovation Pharmaceutical Corporation Information
11.7.2 Dandong Medical Innovation Pharmaceutical Overview
11.7.3 Dandong Medical Innovation Pharmaceutical Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dandong Medical Innovation Pharmaceutical Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dandong Medical Innovation Pharmaceutical Recent Developments
11.8 Sunho
11.8.1 Sunho Corporation Information
11.8.2 Sunho Overview
11.8.3 Sunho Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sunho Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sunho Recent Developments
11.9 SJZ No.4 Pharma
11.9.1 SJZ No.4 Pharma Corporation Information
11.9.2 SJZ No.4 Pharma Overview
11.9.3 SJZ No.4 Pharma Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 SJZ No.4 Pharma Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SJZ No.4 Pharma Recent Developments
11.10 Dongle Pharma
11.10.1 Dongle Pharma Corporation Information
11.10.2 Dongle Pharma Overview
11.10.3 Dongle Pharma Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Dongle Pharma Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Dongle Pharma Recent Developments
11.11 Conba Bio-Pharm
11.11.1 Conba Bio-Pharm Corporation Information
11.11.2 Conba Bio-Pharm Overview
11.11.3 Conba Bio-Pharm Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Conba Bio-Pharm Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Conba Bio-Pharm Recent Developments
11.12 WZT
11.12.1 WZT Corporation Information
11.12.2 WZT Overview
11.12.3 WZT Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 WZT Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 WZT Recent Developments
11.13 Medisan
11.13.1 Medisan Corporation Information
11.13.2 Medisan Overview
11.13.3 Medisan Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Medisan Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Medisan Recent Developments
11.14 Sunflower Pharmaceutical Group
11.14.1 Sunflower Pharmaceutical Group Corporation Information
11.14.2 Sunflower Pharmaceutical Group Overview
11.14.3 Sunflower Pharmaceutical Group Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sunflower Pharmaceutical Group Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sunflower Pharmaceutical Group Recent Developments
11.15 Nipro
11.15.1 Nipro Corporation Information
11.15.2 Nipro Overview
11.15.3 Nipro Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Nipro Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Nipro Recent Developments
11.16 Towa Pharma
11.16.1 Towa Pharma Corporation Information
11.16.2 Towa Pharma Overview
11.16.3 Towa Pharma Methylcobalamin(Mecobalamin) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Towa Pharma Methylcobalamin(Mecobalamin) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Towa Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Methylcobalamin(Mecobalamin) Industry Chain Analysis
12.2 Methylcobalamin(Mecobalamin) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Methylcobalamin(Mecobalamin) Production Mode & Process
12.4 Methylcobalamin(Mecobalamin) Sales and Marketing
12.4.1 Methylcobalamin(Mecobalamin) Sales Channels
12.4.2 Methylcobalamin(Mecobalamin) Distributors
12.5 Methylcobalamin(Mecobalamin) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Methylcobalamin(Mecobalamin) Industry Trends
13.2 Methylcobalamin(Mecobalamin) Market Drivers
13.3 Methylcobalamin(Mecobalamin) Market Challenges
13.4 Methylcobalamin(Mecobalamin) Market Restraints
14 Key Findings in The Global Methylcobalamin(Mecobalamin) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer